Dr. Kirou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
535 E 70th St
New York, NY 10021Phone+1 212-606-1728Fax+1 212-606-1012
Summary
- http://www.hss.edu/physicians_kirou-kyriakos.asp
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 1995 - 1998
- New York-Presbyterian/QueensResidency, Internal Medicine, 1992 - 1995
- Aristotle University of Thessaloniki School of MedicineClass of 1988
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2003 - 2026
- CT State Medical License 2021 - 2025
- NJ State Medical License 1999 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2006
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Nelfinavir in Systemic Lupus Erythematosus Start of enrollment: 2014 Sep 01
- Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) Start of enrollment: 2023 Dec 19
Roles: Contact
- Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine Start of enrollment: 2022 Mar 31
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 140 citationsPlasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8Marie Dominique Ah Kioon, Claudio Tripodo, David Fernandez, Kyriakos A. Kirou, Robert Spiera
Science Translational Medicine. 2018-01-10 - 33 citationsA surge in anti-dsDNA titer predicts a severe lupus flare within six months.N Pan, Isabelle Amigues, Stephen Lyman, Roland Duculan, F Aziz
Lupus. 2014-03-01 - 81 citationsTargeting of Type I Interferon in Systemic Autoimmune DiseasesMary K. Crow, Mikhail Olferiev, Kyriakos A. Kirou
Translational Research. 2015-02-01
Authored Content
- COVID-19 Vaccine Antibody Responses in Patients Treated with B-cell Agents Depend on B-cell Counts at Time of VaccineOctober 2021
Press Mentions
- Neuropsychiatric Symptoms in SLE: Diagnosis and TreatmentAugust 23rd, 2024
- Lupus Subgroup Responds to Anti-CD22April 24th, 2018
- Lupus Patients: The Doctor, Nurse and Social Worker Are Here to See YouNovember 9th, 2010
- Join now to see all
Grant Support
- Post-Transcriptional Regulation Of CD40L In SLENational Institute Of Allergy And Infectious Diseases2003–2007
Professional Memberships
- Fellow
- Fellow
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: